Table 3 Prediction of validation set samples using the proposed multivariate methods
Concentration (µg/mL) | PLS | PCR | ANN | MCR-ALS | |||||
|---|---|---|---|---|---|---|---|---|---|
TRI | XIP | TRI | XIP | TRI | XIP | TRI | XIP | TRI | XIP |
4.00 | 6.00 | 101.55 | 98.22 | 101.56 | 98.22 | 99.75 | 100.16 | 98.75 | 96.66 |
6.00 | 6.00 | 100.02 | 97.22 | 100.03 | 97.21 | 98.80 | 98.95 | 97.52 | 97.26 |
7.00 | 5.00 | 97.58 | 102.29 | 97.58 | 102.29 | 99.71 | 99.70 | 98.59 | 98.06 |
6.00 | 4.00 | 101.23 | 99.96 | 101.23 | 99.96 | 101.30 | 100.10 | 100.79 | 97.75 |
5.00 | 6.00 | 100.71 | 97.72 | 100.71 | 98.71 | 99.38 | 100.03 | 98.92 | 98.39 |
7.00 | 2.00 | 100.81 | 100.17 | 100.81 | 100.17 | 99.49 | 100.19 | 102.11 | 99.21 |
6.00 | 2.00 | 103.53 | 101.22 | 102.23 | 101.23 | 100.90 | 101.54 | 101.21 | 99.16 |
Mean (%) | 100.78 | 99.54 | 100.59 | 99.68 | 99.90 | 100.10 | 99.70 | 98.07 | |
RSD (%) | 1.77 | 1.89 | 1.48 | 1.76 | 0.81 | 0.71 | 1.67 | 0.96 | |